semaglutide cardioprotective In patients with cardiometabolic #HFpEF, #semaglutide and #tirzepatide reduced the risk of hospitalization for heart failure or all-cause mortality compared to sitagliptin, but tirzepatide offered no additional benefit over semaglutide. #ESCCongress We're encouraged by the Quantity:6-Month Pouch weightloss

semaglutide cardioprotective In patients with cardiometabolic #HFpEF, #semaglutide and #tirzepatide reduced the risk of hospitalization for heart failure or all-cause mortality compared to sitagliptin, but tirzepatide offered no additional benefit over semaglutide. #ESCCongress We're encouraged by the Quantity:6-Month Pouch weightloss

We're encouraged by the recent evidence-based guidance issued by the American Diabetes Association (ADA) Obesity Association, which warns against and discourages the use of compounded GLP-1 products due to concerns regarding safety

Conversely, participants with increased PCDNAmTL trended toward greater reductions in HbA1c, hinting at a possible link between semaglutide glycemic improvement and telomere biology

weightloss

Quantity:6-Month Pouch

But the “secret ingredient” that many overlook